Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment
Juliane M. Stosch, Anezka Heumüller, Christoph Niemöller, et al.
British Journal of Haematology (2018) Vol. 182, Iss. 6, pp. 830-842
Open Access | Times Cited: 18

Showing 18 citing articles:

Transitioning single-cell genomics into the clinic
Jennifer Lim, Venessa Chin, Kirsten A. Fairfax, et al.
Nature Reviews Genetics (2023) Vol. 24, Iss. 8, pp. 573-584
Closed Access | Times Cited: 46
Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism
Germana Castelli, Elvira Pelosi, Ugo Testa
Cancers (2019) Vol. 11, Iss. 2, pp. 260-260
Open Access | Times Cited: 34
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes
Matilde Y. Follo, Andrea Pellagatti, Richard N. Armstrong, et al.
Leukemia (2019) Vol. 33, Iss. 9, pp. 2276-2290
Open Access | Times Cited: 28
Bisulfite-free epigenomics and genomics of single cells through methylation-sensitive restriction
Christoph Niemöller, Julius Wehrle, Julian Riba, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 21
The Bright and Dark Side of DNA Methylation: A Matter of Balance
Marta Borchiellini, Simone Ummarino, Annalisa Di Ruscio
Cells (2019) Vol. 8, Iss. 10, pp. 1243-1243
Open Access | Times Cited: 23
Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia
Marta Martín‐Izquierdo, María Abáigar, Jesús María Hernández-Sánchez, et al.
Haematologica (2020) Vol. 106, Iss. 8, pp. 2215-2223
Open Access | Times Cited: 17
New insights into Human Hematopoietic Stem and Progenitor Cells via Single-Cell Omics
Yawen Zhang, Yaojin Huang, Linping Hu, et al.
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 4, pp. 1322-1336
Open Access | Times Cited: 8
Clonal selection in therapy‐related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment
Anne Calleja, Seongseok Yun, Chimène Moreilhon, et al.
European Journal Of Haematology (2020) Vol. 104, Iss. 5, pp. 488-498
Open Access | Times Cited: 11
Preleukemic and leukemic evolution at the stem cell level
Jacob Stauber, John M. Greally, Ulrich Steidl
Blood (2020) Vol. 137, Iss. 8, pp. 1013-1018
Open Access | Times Cited: 10
Blastic transformation of BCR‐ABL1 positive chronic myeloid leukaemia through acquisition of CBFB‐MYH11 and mutant KIT
Khalid Shoumariyeh, Saskia Hussung, Christoph Niemöller, et al.
British Journal of Haematology (2020) Vol. 190, Iss. 6
Open Access | Times Cited: 6
Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation
Ran Zhang, Xuan Lu, Liang Tang, et al.
Bone Marrow Transplantation (2022) Vol. 57, Iss. 7, pp. 1063-1071
Closed Access | Times Cited: 4
Identification of enhancer of mRNA decapping 4 as a novel fusion partner of MLL in acute myeloid leukemia
Heiko Becker, Gabriele Greve, Keisuke Kataoka, et al.
Blood Advances (2019) Vol. 3, Iss. 5, pp. 761-765
Open Access | Times Cited: 4
Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression
Anita Tranberg Simonsen, Marie Bill, Carina Agerbo Rosenberg, et al.
Leukemia Research (2020) Vol. 92, pp. 106350-106350
Closed Access | Times Cited: 2
Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019
Konnie M. Hebeda, L Boudová, Christine Beham‐Schmid, et al.
Annals of Hematology (2020) Vol. 100, Iss. 1, pp. 117-133
Closed Access | Times Cited: 2
Clinically Significant CUX1 Mutations Are Frequently Subclonal and Common in Myeloid Disorders With a High Number of Co-mutated Genes and Dysplastic Features
Josephine K. Dermawan, Christine Wensel, Valeria Visconte, et al.
American Journal of Clinical Pathology (2021) Vol. 157, Iss. 4, pp. 586-594
Closed Access | Times Cited: 1
Gene mutations in a patient with chronic myelomonocytic leukemia and changes upon progression to acute myeloid leukemia and during treatment*
Junmin Li, Sujiang Zhang
Oncology and Translational Medicine (2019) Vol. 5, Iss. 1, pp. 30-32
Open Access
Impacto de las mutaciones somáticas en pacientes con síndromes mielodisplásticos sometidos a distintas modalidades de tratamiento
Juan Carlos Caballero Berrocal
(2020)
Open Access
[Risk factors for leukemia transformation in patients with myelodysplastic syndromes].
Songyang Zhao, Zefeng Xu, T J Qin, et al.
PubMed (2022) Vol. 43, Iss. 10, pp. 818-825
Closed Access
Page 1

Scroll to top